Cite
APA Citation
Kulkarni, R., Hodder, S. L., Cao, H., Chang, S., Miller, M. D., & White, K. L. (2017). week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128). HIV clinical trials, 18(4), 164–173. http://access.bl.uk/ark:/81055/vdc_100049476343.0x000050